Akums Subsidiary Acquires Oriflame Plants for ₹56 Crore

Date: July 23, 2026

Pure and Cure Healthcare Private Limited, a wholly-owned subsidiary of Akums Drugs and Pharmaceuticals Limited, at its Board Meeting held on July 23, 2026, approved acquisition of Oriflame India Private Limited's manufacturing business for total consideration of INR 56 Crore.

Acquisition includes two manufacturing plants at Roorkee, Uttarakhand and Noida, Uttar Pradesh, along with a leased warehouse situated at Noida.
The trademark and marketing of Oriflame's products in India is not part of this transaction.
Cosmetics is identified as a fast-growing opportunity in India, marking Akums' entry into color cosmetics and expanding its presence in skincare & wellness products.
The acquisition will expand Akums' manufacturing capacity as well as capability of cosmetic and wellness products for Indian as well as global markets.

Consideration: Cash consideration of INR 56 Crores
Expected completion date: By 31st August 2026
No prior governmental or regulatory approvals required
Not a related party transaction - promoter/promoter group/group companies have no interest in the entity being acquired
No entity is being acquired - only manufacturing business assets